The novel coronavirus continues to be featured all over the media in 2022. After more than two years of this pandemic, we have already addressed the fact that things seem to be getting back to normal these days.
Important cardiologist Peter McCullough notes the following tweet that managed to give hope for the better. Check out his message below in which the expert says that after more than 2 years of studies, even people who are the frailest can survive the disease triggered by the novel coronavirus.
I worked with teams of doctors to develop and refine the “McCullough Protocol” for this very scenario. Millions of lives have been saved relying upon these important treatment principles. After two years, there is global understanding and even those most frail can survive. pic.twitter.com/nPt5L1VnQu
— Peter McCullough, MD MPH (@P_McCulloughMD) February 21, 2022
Lots of people congratulated the expert for all the help that he has been providing via his studies.
Your protocol is brilliant, and sad it was not nationally implemented at the outset. Good data and real facts count for nothing now. I live in stunned mode. ✌️????
— Jim Kellerher (@photogshoot) February 21, 2022
Pfizer board member addresses the end of the pandemic
Not too long ago, we were revealing that an extremely important pharmaceutical executive is saying that pandemic-related restrictions could be relaxed.
This is happening as cases decline in some areas following a surge of the milder Omicron variant.
Dr. Scott Gottlieb is a former director of the Food and Drug Administration (FDA) and current board member at Pfizer.
“I think certainly on the East Coast, where you see cases declining dramatically, we need to be willing to lean in and do that very soon I think as conditions improve we have to be willing to relax some of these measures with the same speed that we put them in place.”
This is what he said on CNBC.